Smoldering multiple myeloma associated with a acquired von Willebrand syndrome, successfully treated by daratumumab, lenalidomide and dexamethasone

被引:0
|
作者
Iarossi, Michael [1 ]
Vekemans, Marie-Christiane Madeleine [2 ]
Weynants, Nicolas [3 ]
Hermans, Cedric [1 ]
机构
[1] St Luc Hosp, St Lambert, Belgium
[2] Univ Catholique Louvain UCLouvain, Dept Internal Med, Brussels, Belgium
[3] Hop Arlon, Arlon, Belgium
来源
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P-427
引用
收藏
页码:S276 / S276
页数:1
相关论文
共 50 条
  • [1] Acquired von Willebrand Syndrome Associated with a Smoldering Multiple Myeloma, Successfully Treated by Daratumumab, Lenalidomide, and Dexamethasone
    Iarossi, Michael
    Vekemans, Marie-Christiane Madeleine
    Weynants, Nicolas
    Hermans, Cedric
    ACTA HAEMATOLOGICA, 2024, 147 (05) : 587 - 591
  • [2] Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma
    Dimopoulos, M. A.
    Oriol, A.
    Nahi, H.
    San-Miguel, J.
    Bahlis, N. J.
    Usmani, S. Z.
    Rabin, N.
    Orlowski, R. Z.
    Komarnicki, M.
    Suzuki, K.
    Plesner, T.
    Yoon, S. -S.
    Ben Yehuda, D.
    Richardson, P. G.
    Goldschmidt, H.
    Reece, D.
    Lisby, S.
    Khokhar, N. Z.
    O'Rourke, L.
    Chiu, C.
    Qin, X.
    Guckert, M.
    Ahmadi, T.
    Moreau, P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (14): : 1319 - 1331
  • [3] Disseminated Cryptococcosis in a Patient with Multiple Myeloma Treated with Daratumumab, Lenalidomide, and Dexamethasone
    Sato, Shuku
    Kambe, Emiko
    Tamai, Yotaro
    INTERNAL MEDICINE, 2019, 58 (06) : 843 - 847
  • [4] Acquired von Willebrand syndrome in multiple myeloma
    Djunic, Irena
    Elezovic, Ivo
    Ilic, Vesna
    Tomin, Dragica
    Suvajdzic-Vukovic, Nada
    Bila, Jelena
    Antic, Darko
    Vidovic, Ana
    Milosevic-Jovcic, Nadezda
    HEMATOLOGY, 2011, 16 (04) : 209 - 212
  • [5] Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
    Sonneveld, Pieter
    Dimopoulos, Meletios A.
    Boccadoro, Mario
    Quach, Hang
    Ho, P. Joy
    Beksac, Meral
    Hulin, Cyrille
    Antonioli, Elisabetta
    Leleu, Xavier
    Mangiacavalli, Silvia
    Perrot, Aurore
    Cavo, Michele
    Belotti, Angelo
    Broijl, Annemiek
    Gay, Francesca
    Mina, Roberto
    Nijhof, Inger S.
    van de Donk, Niels W. C. J.
    Katodritou, Eirini
    Schjesvold, Fredrik
    Sureda Balari, Anna
    Rosinol, Laura
    Delforge, Michel
    Roeloffzen, Wilfried
    Silzle, Tobias
    Vangsted, Annette
    Einsele, Hermann
    Spencer, Andrew
    Hajek, Roman
    Jurczyszyn, Artur
    Lonergan, Sarah
    Ahmadi, Tahamtan
    Liu, Yanfang
    Wang, Jianping
    Vieyra, Diego
    van Brummelen, Emilie M. J.
    Vanquickelberghe, Veronique
    Sitthi-Amorn, Anna
    de Boer, Carla J.
    Carson, Robin
    Rodriguez-Otero, Paula
    Blade, Joan
    Moreau, Philippe
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (04): : 301 - 313
  • [6] Progressive multifocal leukoencephalopathy in multiple myeloma associated with daratumumab, lenalidomide, and dexamethasone
    Seko, Kento
    Uchida, Yuto
    Kanamori, Takashi
    Sakurai, Keita
    Usami, Toshihiko
    Kuno, Tomoyuki
    Takada, Koji
    Nakamichi, Kazuo
    Matsukawa, Noriyuki
    NEUROLOGY AND CLINICAL NEUROSCIENCE, 2022, 10 (03): : 163 - 166
  • [7] Phase II Trial of Daratumumab, Bortezomib, Lenalidomide and Dexamethasone in High-Risk Smoldering Multiple Myeloma
    Nadeem, Omar
    Magidson, Sophie
    Redd, Robert A.
    Laubach, Jacob
    Mo, Clifton C.
    O'Donnell, Elizabeth K.
    Sperling, Adam S.
    Hartley-Brown, Monique A.
    Midha, Shonali
    Marto, Marjorie
    Davie, Christine
    Ricciardi, Caroline
    Choden, Dechen
    Strutevant, Ashlee
    Alberti, Jillian
    Trippa, Lorenzo
    Munshi, Nikhil C.
    Anderson, Kenneth C.
    Richardson, Paul G.
    Ghobrial, Irene M.
    BLOOD, 2023, 142
  • [8] Acquired von Willebrand syndrome in patients with multiple myeloma
    Djunic, I. S.
    Elezovic, I
    Jovcic, Milosevic N.
    Ilic, V
    Antic, D.
    Vidovic, A.
    Tomin, D.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 841 - 841
  • [9] Phase II trial of daratumumab, bortezomib, lenalidomide and dexamethasone in high-risk smoldering multiple myeloma
    Nadeem, Omar
    Redd, Robert
    Mo, Clifton
    Laubach, Jacob
    Richardson, Paul G.
    Prescott, Julia
    Marto, Marjorie
    Davie, Christine
    Ricciardi, Caroline
    Murphy, Elizabeth
    Bertoni, Meredith
    Choden, Dechen
    Magidson, Sophie
    Sheehan, Brian
    Shrestha, Hira
    Sperling, Adam S.
    O'Donnell, Elizabeth K.
    Ghobrial, Irene M.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S89 - S89
  • [10] Digestive angiodysplasia revealing an acquired von Willebrand syndrome associated to a multiple myeloma
    Reggoug, Sanae
    Errabih, Krame
    Benzzoubeir, Nadia
    Krami, Flayat
    Ouazzani, Laziza
    Amrani, Naima
    Ouazzani, Houria
    ACTA ENDOSCOPICA, 2007, 37 (04) : 547 - 557